|
|
Article: Bioxel Pharma Inc. - Financial and Strategic Analysis Review.
- Article from:
- M2 Presswire
- Article date:
- May 4, 2009
CopyrightCOPYRIGHT 2009 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-4 May 2009-www.companiesandmarkets.com: Bioxel Pharma Inc. - Financial and Strategic Analysis Review(C)1994-2009 M2 COMMUNICATIONS LTD
RDATE:04052009
-www.companiesandmarkets.com adds new report: Bioxel Pharma Inc. - Financial and Strategic Analysis Review
Bioxel Pharma Inc. - Financial and Strategic Analysis Review
Summary
Bioxel Pharma Inc. (Bioxel) is a biopharmaceutical company. The company is focused on the manufacture and distribution of taxane active pharmaceutical ingredients (APIs) namely paclitaxel and docetaxel, which are widely used in cancer treatment, as well as its starting materials 9-DHB and ...